pnb-0408 dihexa clinical trial peptide effects dihexa solubility in dmf Dihexa (also known as PNB- 0408) is an experimental small molecule derived Dihexa | c-Met/HGFR | TargetMol
Description
The half-life of BPC-157 was reported to be less than 30 minutes, following linear phar- macokinetics, after single and repeat intramuscular and intravenous dose administration
Russian preclinical literature on stress-axis modulation
Rats given BPC-157 after ligament injuries showed faster recovery and improved tissue quality
EU country law applies.
